Upcoming event
14th European Multidisciplinary Congress on Urological Cancers

Article of the Month

Stereotactic ablative radiation for systemic therapy–naïve oligometastatic kidney cancer

SAbR for oligometastatic RCC was associated with meaningful longitudinal disease control while preserving QOL. These data support further evaluation of SAbR for systemic therapy–naïve oligometastatic RCC.

Upcoming events

10
Nov
2022

14th European Multidisciplinary Congress on Urological Cancers

Budapest, Hungary
10
Nov
2022

10th Meeting of the EAU Section of Urological Imaging

Budapest, Hungary
17
Nov
2022

ESU-ESUT Masterclass on Lasers in urology

Barcelona, Spain

EAU22 interviews

New surgical development in renal cancer surgery

Watch now

Watch now

Updated results from the 30-month follow-up of KEYNOTE-564

Watch now

Watch now

EAU Guidelines on RCC

EAU Guidelines on RCC

Articles

Pembrolizumab outperforms tyrosine kinase inhibitors in the adjuvant therapy of patients with high-risk renal cell carcinoma: A systematic review and network meta-analysis

Decision-making and management strategies for patients with bilateral synchronous non-metastatic renal masses: Insights from a multi-centre European dataset